FBRX (Forte Biosciences) FCF Margin %: 0.00% (As of Mar. 2026)


FBRX Forte Biosciences Inc FBRX
35 GF Score
Price $19.91
! 2 Warning Signs
View Full Analysis

What is Forte Biosciences FCF Margin %?

Forte Biosciences FBRX +6.19% 35 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates FBRX with a GF Score™ of 35/100. The stock has 2 warning signs investors should review. Among 959 Biotechnology companies, Forte Biosciences ranks worse than 104275.18% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Forte Biosciences's Free Cash Flow for the three months ended in Mar. 2026 was $-18.81 Mil. Forte Biosciences's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, Forte Biosciences's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Forte Biosciences's current FCF Yield % is -14.57%.

The historical rank and industry rank for Forte Biosciences's FCF Margin % or its related term are showing as below:


FBRX's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -84.65
* Ranked among companies with meaningful FCF Margin % only.

Forte Biosciences FCF Margin % Related Terms

Forte Biosciences FCF Margin % Historical Data

* Premium members only.

The historical data trend for Forte Biosciences's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Forte Biosciences FCF Margin % Chart

Forte Biosciences Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Forte Biosciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

FBRX vs OABI, VNDA, ARTV: FCF Margin % Comparison

For the Biotechnology subindustry, Forte Biosciences's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Forte Biosciences FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Forte Biosciences's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Forte Biosciences's FCF Margin % falls into.


FBRX
35GF Score
Forte Biosciences Inc FBRX
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Forte Biosciences FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Forte Biosciences's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-50.998/0
= %

Forte Biosciences's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-18.808/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Forte Biosciences (FBRX) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Forte Biosciences and its competitors. According to the industry distribution chart, Forte Biosciences ranks #999999 out of 959 companies in the Biotechnology industry.
Is Forte Biosciences' FCF Margin % too high?
Forte Biosciences' current FCF Margin % is 0.00%. Based on the distribution chart, Forte Biosciences ranks #999999 out of 959 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Forte Biosciences has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Forte Biosciences' FCF Margin % compare to OABI and VNDA?
According to the Biotechnology industry distribution chart, Forte Biosciences ranks #999999 out of 959 companies for FCF Margin %. This places Forte Biosciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Forte Biosciences and its competitors. Forte Biosciences's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Forte Biosciences stock overvalued right now?
Forte Biosciences (FBRX) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Forte Biosciences' overall GF Score™ is 35/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Forte Biosciences (FBRX), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Forte Biosciences Business Description

Other Exchanges 37T:Germany
Address 3060 Pegasus Park Drive, Building 6, Dallas, TX, USA, 75247
Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.
35GF Score

Get the complete analysis for FBRX

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$19.91
Price